BenchSci

BenchSci
BenchSci

BenchSci exponentially increases the speed and quality of life-saving research by empowering scientists with the world's most advanced biomedical artificial intelligence to run more successful experiments. Backed by Google's AI fund, Gradient Ventures, BenchSci uses machine learning to provide scientists with the knowledge to plan more successful experiments, eliminate unnecessary work, and reduce downstream risk. A turnkey application of AI with immediate, quantifiable impact, BenchSci now optimizes experimental success in 15 of the top 20 pharmaceutical companies and over 4,300 leading academic centers globally.